DNMR Stock Forecast 2025-2026
Distance to DNMR Price Targets
DNMR Price Momentum
10 Quality Stocks Worth Considering Now
Researching Danimer (DNMR) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on DNMR and similar high-potential opportunities.
Latest DNMR Stock Price Targets & Analyst Predictions
Based on our analysis of 4 Wall Street analysts, DNMR has a neutral consensus with a median price target of $4.50 (ranging from $4.50 to $4.50). Currently trading at $0.35, the median forecast implies a 1,185.7% upside. This outlook is supported by 0 Buy, 1 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Charles Neivert at Piper Sandler, projecting a 1,185.7% upside. Conversely, the most conservative target is provided by Charles Neivert at Piper Sandler, suggesting a 1,185.7% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
DNMR Analyst Ratings
DNMR Price Target Range
Latest DNMR Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for DNMR.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Aug 21, 2024 | Piper Sandler | Charles Neivert | Neutral | Maintains | $1.00 |
| Aug 13, 2024 | TD Cowen | Hold | Downgrade | $0.00 | |
| May 22, 2024 | Jefferies | Laurence Alexander | Hold | Downgrade | $0.80 |
| Apr 9, 2024 | Piper Sandler | Charles Neivert | Neutral | Downgrade | $1.25 |
| Apr 4, 2024 | TD Cowen | Thomas Boyes | Buy | Maintains | $2.00 |
| Oct 11, 2023 | Piper Sandler | Charles Neivert | Overweight | Maintains | $4.00 |
| Jun 1, 2023 | Piper Sandler | Charles Neivert | Overweight | Maintains | $8.00 |
| Apr 3, 2023 | Piper Sandler | Charles Neivert | Overweight | Maintains | $7.00 |
| Oct 12, 2022 | Piper Sandler | Charles Neivert | Overweight | Initiates | $4.50 |
| Sep 23, 2021 | Cowen & Co. | Thomas Boyes | Outperform | Initiates | $21.00 |
Danimer Scientific Inc. (DNMR) Competitors
The following stocks are similar to Danimer based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Danimer Scientific Inc. (DNMR) Financial Data
Danimer Scientific Inc. has a market capitalization of $739,873 with a P/E ratio of 0.0x. The company generates $37.43M in trailing twelve-month revenue with a -297.1% profit margin.
Revenue growth is -21.2% quarter-over-quarter, while maintaining an operating margin of -217.3% and return on equity of -43.1%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Danimer Scientific Inc. (DNMR) Business Model
About Danimer Scientific Inc.
Develops biodegradable plastic solutions.
The company generates revenue by producing and supplying biodegradable PHA-based plastics that serve as alternatives to traditional plastics. Their products cater to various industries, including packaging, consumer goods, and agriculture, capitalizing on the increasing demand for sustainable materials.
Danimer Scientific is strategically positioned in the growing bioplastics market, which is driven by the rising focus on sustainability and environmental responsibility. As consumer preferences shift towards eco-friendly products, the company stands to benefit from investments in green technology and innovation.
Company Information
Sector
Basic Materials
Industry
Specialty Chemicals
Employees
257
CEO
Mr. Richard N. Altice
Country
United States
IPO Year
2012
Website
www.danimerscientific.comDanimer Scientific Inc. (DNMR) Latest News & Analysis
The NYSE will delist Danimer Scientific, Inc. (ticker: DNMR) and has suspended trading of its Class A common stock, following a decision by NYSE Regulation.
Delisting from the NYSE typically indicates financial distress or regulatory issues, raising concerns about the company's viability and affecting investor confidence and stock value.
Danimer Scientific Announces Common Stock Expected to Begin Trading Promptly on OTCQX Marketplace
2 months agoDanimer Scientific, Inc. (NYSE: DNMR) announced the NYSE has suspended trading of its stock and initiated the delisting process due to regulatory determinations.
Suspension and potential delisting from the NYSE signal financial distress for Danimer Scientific, likely affecting investor confidence and stock value.
Danimer Scientific, Inc. (NYSE: DNMR) has issued an $11.25 million super senior secured promissory note to lenders under its term loan financing agreement to support its biodegradable materials development.
Danimer Scientific's issuance of a secured loan indicates financial maneuvering to support operations, which could affect liquidity and future growth prospects, influencing investor sentiment.
TerraNova Capital Equities' Structure Finance Group advised Danimer Scientific (NYSE: DNMR) on a $20 million revolving credit facility in three recent transactions.
TerraNova's advisory role in securing a $20 million credit facility for Danimer Scientific indicates increased financial support, potentially enhancing DNMR's growth prospects and investor confidence.
Danimer Scientific, Inc. (NYSE:DNMR) will hold its Q3 2024 Earnings Conference Call on November 19, 2024, at 10:00 AM ET with Interim CEO Rich Altice and CFO Mike Hajost.
Danimer Scientific's Q3 earnings call could reveal financial performance and strategic insights, impacting stock valuation and investor sentiment.
Danimer Scientific (NYSE: DNMR) reported Q3 financial results for the period ending September 30, 2024, meeting expectations despite temporary impacts from Starbucks' reapportionment.
Danimer's financial results reflect stability amid challenges, influencing investor confidence in its growth potential within the bioplastics sector. Performance aligns with expectations, crucial for future valuations.
Frequently Asked Questions About DNMR Stock
What is Danimer Scientific Inc.'s (DNMR) stock forecast for 2025?
Based on our analysis of 4 Wall Street analysts, Danimer Scientific Inc. (DNMR) has a median price target of $4.50. The highest price target is $4.50 and the lowest is $4.50.
Is DNMR stock a good investment in 2025?
According to current analyst ratings, DNMR has 0 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $0.35. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for DNMR stock?
Wall Street analysts predict DNMR stock could reach $4.50 in the next 12 months. This represents a 1,185.7% increase from the current price of $0.35. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Danimer Scientific Inc.'s business model?
The company generates revenue by producing and supplying biodegradable PHA-based plastics that serve as alternatives to traditional plastics. Their products cater to various industries, including packaging, consumer goods, and agriculture, capitalizing on the increasing demand for sustainable materials.
What is the highest forecasted price for DNMR Danimer Scientific Inc.?
The highest price target for DNMR is $4.50 from Charles Neivert at Piper Sandler, which represents a 1,185.7% increase from the current price of $0.35.
What is the lowest forecasted price for DNMR Danimer Scientific Inc.?
The lowest price target for DNMR is $4.50 from Charles Neivert at Piper Sandler, which represents a 1,185.7% increase from the current price of $0.35.
What is the overall DNMR consensus from analysts for Danimer Scientific Inc.?
The overall analyst consensus for DNMR is neutral. Out of 4 Wall Street analysts, 0 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $4.50.
How accurate are DNMR stock price projections?
Stock price projections, including those for Danimer Scientific Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
